Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective
Marcin Kowanetz, Napoleone Ferrara · Clinical Cancer Research · 2006
The establishment of a vascular supply is one of the earliest and most important events occurring during embryonic development. Growth and maturation of a functional vascular network are complex and still incompletely understood processes involving orchestrated activation of vascular progenitors in the early stages of embryonic development followed by vasculogenesis and angiogenesis. These processes require a tightly regulated activation of several growth factors and their receptors. The role of vascular endothelial growth factors (VEGF) and their receptors has been studied extensively due to their prominent role during blood vessel formation. Mice deficient in various VEGF ligands or receptors show serious defects in vascular formation and maturation. Moreover, members of the VEGF family are involved in other significant biological processes, including lymphangiogenesis, vascular permeability, and hematopoiesis. Importantly, VEGF is released by tumor cells and induces tumor neovascularization. It is now well established that the VEGF axis represents an important target for antitumor therapy. Aberrant VEGF signaling is also a feature of several other pathologic conditions, such as age-related macular degeneration and rheumatoid arthritis.
Cited by 564 works. doi:10.1158/1078-0432.ccr-06-1520
Authors
References
- Tumor Angiogenesis: Therapeutic Implications
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
- The biology of VEGF and its receptors
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
- The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
- The Biology of Vascular Endothelial Growth Factor
- Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
- The Vascular Endothelial Growth Factor Family: Identification of a Fourth Molecular Species and Characterization of Alternative Splicing of RNA